Nicolò Borsellino

Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.

Nicolò Borsellino, Arie S. Belldegrun, Benjamin Bonavida · PubMed · 1995 · 173 citations

Chemoprevention Strategy, Il-6 Secretion, Immunology +19

Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients’ Queries, Needs, Fears, and Actions Taken

Vittorio Gebbia, Dario Piazza, Maria Rosaria Valerio et al. · JCO Global Oncology · 2020 · 67 citations · Full text

Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.

Rüçhan Uslu, Nicolò Borsellino, Patrick Frost et al. · PubMed · 1997 · 65 citations

Subtoxic Concentrations, Apoptosis, Immunology +17

Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer

Vittorio Gebbia, M Bellavia, Giuseppe Luigi Banna et al. · Clinical Lung Cancer · 2013 · 54 citations

Second-line Erlotinib, Treatment Monitoring Program, Oncology +6

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

Vittorio Gebbia, Evaristo Maiello, Francesco Giuliani et al. · Annals of Oncology · 2007 · 54 citations

Surgical Oncology, Folfox4 Regimen, Pancreatic Cancer +9